Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.290
0.00 (0.00%)
Sep 18, 2026, 10:02 AM EDT - Market open
CNTB Revenue
Connect Biopharma Holdings had revenue of $2.77M in the quarter ending June 30, 2026, with 5,666.67% growth. This brings the company's revenue in the last twelve months to $2.95M, up 50.28% year-over-year. In the year 2025, Connect Biopharma Holdings had annual revenue of $64.00K, down -99.75%.
Revenue (ttm)
$2.95M
Revenue Growth
+50.28%
P/S Ratio
27.51
Revenue / Employee
$46,141
Employees
64
Market Cap
81.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 64.00K | -25.97M | -99.75% |
| Dec 31, 2024 | 26.03M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Jan 1, 2022 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Fortress Biotech | 68.47M |
| BioStem Technologies | 34.59M |
| Verrica Pharmaceuticals | 30.32M |
| RenovoRx | 1.98M |
| iBio, Inc. | 100.00K |
| NeOnc Technologies Holdings | 39.99K |
CNTB News
- 2 days ago - Connect Biopharma price target lowered to $6 from $7 at Canaccord - TheFly
- 2 days ago - Connect Biopharma Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 3 days ago - Connect Biopharma Holdings Transcript: Study result - Transcripts
- 3 days ago - Connect Biopharma Holdings Press release: Study result - Filings
- 3 days ago - Connect Biopharma Holdings Slides: Study result - Filings
- 3 days ago - Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation - GlobeNewsWire
- 3 days ago - Connect Biopharma Holdings Slides: Corporate presentation - Filings
- 14 days ago - Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire